Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies

Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies

Shape CEO Francois Vigneault. (Shape photo) Shape Therapeutics, a Seattle preclinical biotech company developing RNA editing and gene therapy technologies, has raised $ 112 million. The company’s RNA editing technologies come from the laboratory of co-founder Prashant Mali, a bio-engineer at the University of California, San Diego, who sits on Shape’s scientific advisory board. Shape … Read more

New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research

New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research

Assistant Professor Melody Campbell prepares a sample in the Cryo-EM Laboratory for Shared Resources at the Fred Hutchinson Cancer Research Center in Seattle. (Fred Hutch photo) Dr. Melody Campbell was an undergraduate student when she first noticed the beauty and power of cryogenic electron microscopy (cryo-EM), a technique that uses extreme temperatures and an electron … Read more